EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adverse event profile differences among long-acting gonadotropin-releasing hormone analogs: A real-world, pharmacovigilance study

Yuting Chen iD, Weitao Lu, Ruilian Liao, Ximin Zhang, Wang Chen, Jing Wang, Huancun Feng iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0327842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yuting Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2024 PSM Guangdong Pharmaceutical Science Research Fund, 2024 Guangdong Provincial universities characteristic innovation project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-acting Gonadotropin-releasing hormone analogs(GnRHa), including leuprolide, goserelin, histrelin, buserelin, triptorelin, have been widely used for a variety of diseases including prostate cancer, breast cancer, endometriosis, uterine leiomyomas, and central precocious puberty (CPP). However, their real-world safety profile differences have not been adequately compared.

Objective

We aimed to investigate the adverse event (AE) profile differences of long-acting GnRHa reported by the US Food and Drug Administration Adverse Event Reporting System (FAERS).

Methods

All indications were searched long-acting GnRHa, as primary suspect drugs, from FAERS data (January 2004 to September 2023). We performed disproportionality analyses by reporting odds ratios (ROR) and conducted univariate and multivariate logistical regression analyses to determine the odds ratio (OR) of serious AEs associated with long-acting GnRHa under different exposure factors.

Results

Reproductive system and breast disorders accounted for the greatest proportion of adverse events among the five long-acting GnRHa formulations analyzed. Both buserelin and histrelin showed distinct adverse effect profiles, with buserelin demonstrating a higher incidence of gastrointestinal disorders and histrelin showing a greater propensity for psychiatric disorders. Logistic regression analysis revealed these five medications carried an elevated risk of significant medical events, and this risk was notably lower in pediatric patients (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gonadotropin-Releasing HormoneDrug-Related Side Effects and Adverse ReactionsHumansPharmacovigilanceFemaleMaleAdultAdverse Drug Reaction Reporting SystemsMiddle AgedChildAdolescentUnited StatesLeuprolideBuserelinTriptorelin PamoateAgedYoung AdultGoserelinDelayed-Action Preparations

Substanzen

Gonadotropin-Releasing HormoneLeuprolideBuserelinTriptorelin PamoateGoserelinhistrelinDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Pharmacy, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, Guangdong, China.
  • School of Pharmaceutical sciences, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Pharmacy, Jiangmen Central Hospital, Jiangmen, Guangdong, China.
  • Sun Yat-Sen University Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China.
  • Guangzhou Civil Aviation College, Guangzhou, Guangdong, China.
  • Department of Pharmacy, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.

ORCID-Profile: Yuting Chen, Huancun Feng

Förderung

  • 2024 PSM Guangdong Pharmaceutical Science Research Fund
  • 2024 Guangdong Provincial universities characteristic innovation project

Zitieren

APA

Chen, Y., Lu, W., Liao, R., Zhang, X., Chen, W., Wang, J., & Feng, H. (2025). Adverse event profile differences among long-acting gonadotropin-releasing hormone analogs: A real-world, pharmacovigilance study. PLOS One. https://doi.org/10.1371/journal.pone.0327842

Vancouver

Chen Y, Lu W, Liao R, Zhang X, Chen W, Wang J, et al. Adverse event profile differences among long-acting gonadotropin-releasing hormone analogs: A real-world, pharmacovigilance study. PLOS One. 2025. doi:10.1371/journal.pone.0327842

BibTeX
@article{Chen2025,
  author = {Chen, Yuting and Lu, Weitao and Liao, Ruilian and Zhang, Ximin and Chen, Wang and Wang, Jing and Feng, Huancun},
  title = {Adverse event profile differences among long-acting gonadotropin-releasing hormone analogs: A real-world, pharmacovigilance study},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327842}
}
Kostenlos starten →